Certara Products - Phoenix Archives | 第 3 页，共 4 页

Case Study

一家生物技术初创公司如何通过转用 Phoenix Hosted提高灵活性和效率

Discover how a biotech startup enhanced flexibility and efficiency by adopting Phoenix Hosted, streamlining workflows…

Danielle Pillsbury2023 年 9 月 8 日

Case Study

利用药代动力学建模和科学传播专长推进肉样瘤病药物项目

Certara's support, from dose optimization to medical writing, helps pharmaceutical companies advance their research, make…

Danielle Pillsbury2023 年 6 月 1 日

Blog

Application of PK/PD Modeling and Simulation in Drug Discovery and Development in China

By Yuancheng Chen, Research Associate of Phase 1 Unit, Huashan Hospital, Fudan University, and visiting…

Certara2020 年 8 月 7 日

Blog

Reference-scaled Average Bioequivalence

The standard approach for approval of generic drugs is to run a bioequivalence study to…

Certara2016 年 5 月 12 日

博客

Conventional & Mechanistic IVIVC: Complementary or Clashing Methods?

An IVIVC (in vitro-in vivo correlation) is a mathematical relationship that predicts key pharmacokinetic parameters…

Certara2016 年 2 月 9 日

Blog

关于计算机系统验证的常见误解

Drug development professionals frequently use computer systems to help them understand the pharmacokinetics (PK) and…

Certara2015 年 1 月 28 日

Blog

Using Modeling and Simulation to Quantify the PK of an Anti-HIV Drug for Babies

As a scientist at Certara and proud Dad to my three kids, pediatric drug development…

Certara2015 年 1 月 15 日

Blog Knowledge Base

Understanding Steady State Pharmacokinetics

“Steady state” is an important term in pharmacokinetics, but it can often seem a bit…

Certara2013 年 11 月 25 日

Blog Knowledge Base

Calculating Urine PK Parameters

Pharmacokinetic analysis normally focuses on systemic exposure to a drug; however, much can be learned…

Certara2012 年 12 月 6 日

Blog Knowledge Base

The Difference Between Vd and Vss

There are many terms used to represent volume of distribution, but two common ones are…

Certara2011 年 3 月 31 日

Certara Products – Phoenix

一家生物技术初创公司如何通过转用 Phoenix Hosted提高灵活性和效率

利用药代动力学建模和科学传播专长推进肉样瘤病药物项目

Application of PK/PD Modeling and Simulation in Drug Discovery and Development in China

Reference-scaled Average Bioequivalence

Conventional & Mechanistic IVIVC: Complementary or Clashing Methods?

关于计算机系统验证的常见误解

Using Modeling and Simulation to Quantify the PK of an Anti-HIV Drug for Babies

Understanding Steady State Pharmacokinetics

Calculating Urine PK Parameters

The Difference Between Vd and Vss

订阅时事通讯

快捷链接

解决方案

联系我们